Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Sales (2016 - 2025)

Avanos Medical (AVNS) has disclosed Return on Sales for 13 consecutive years, with 0.0% as the latest value for Q3 2025.

  • Quarterly Return on Sales rose 1.0% to 0.0% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Sep 2025, up 1.0% year-over-year, with the annual reading at 0.01% for FY2024, 7.0% up from the prior year.
  • Return on Sales hit 0.0% in Q3 2025 for Avanos Medical, up from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.21% in Q2 2021 to a low of 0.72% in Q4 2021.
  • Historically, Return on Sales has averaged 0.05% across 5 years, with a median of 0.0% in 2025.
  • Biggest five-year swings in Return on Sales: crashed -45bps in 2021 and later surged 76bps in 2022.
  • Year by year, Return on Sales stood at 0.72% in 2021, then surged by 106bps to 0.04% in 2022, then crashed by -107bps to 0.0% in 2023, then soared by 42bps to 0.0% in 2024, then surged by 74bps to 0.0% in 2025.
  • Business Quant data shows Return on Sales for AVNS at 0.0% in Q3 2025, 0.0% in Q2 2025, and 0.01% in Q1 2025.